000 03372nam a22005655i 4500
001 978-1-4614-4759-7
003 DE-He213
005 20140220083250.0
007 cr nn 008mamaa
008 120830s2012 xxu| s |||| 0|eng d
020 _a9781461447597
_9978-1-4614-4759-7
024 7 _a10.1007/978-1-4614-4759-7
_2doi
050 4 _aTP155-156
072 7 _aTDC
_2bicssc
072 7 _aSCI013060
_2bisacsh
082 0 4 _a660
_223
100 1 _aFatunde, Olumurejiwa A.
_eauthor.
245 1 0 _aMedical Devices and Biomaterials for the Developing World
_h[electronic resource] :
_bCase Studies in Ghana and Nicaragua /
_cby Olumurejiwa A. Fatunde, Sujata K. Bhatia.
264 1 _aNew York, NY :
_bSpringer New York :
_bImprint: Springer,
_c2012.
300 _aXVIII, 112 p. 41 illus., 11 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aSpringerBriefs in Public Health,
_x2192-3698
505 0 _aIntroduction -- Case study of Ghana -- Case study of Nicaragua -- Corn and soy-derived materials: Properties and potential clinical applications -- Feasibility study of corn- and soy-derived materials -- Discussion, recommendations, and conclusion.
520 _aMedical Devices and Biomaterials for the Developing World focuses on the adoption of medical technology in the developing world, specifically focusing on the the role that new biomaterials can play. It explores the difficulties that accompany the successful transfer of technologies between disparate settings, focusing on the cases of Ghana and Nicaragua as examples of the broader situations in West Africa and Central and South America. These two regions are uniquely positioned with regard to health care and technological capabilities, and both stand to grow significantly in the coming years. Biomaterials represent an enormous opportunity for developing societies to become active participants in the development of new technologies, and can be used in the treatment of diseases throughout the developing world and beyond. The authors of this book argue that advanced technology should be aligned with the needs of developing and emerging markets, and that an alternative definition of technology should be embraced: one that considers natural sources for materials and tools for treatment, and that is not restricted to traditional computerized and electronic technologies.
650 0 _aChemistry.
650 0 _aPolymers.
650 0 _aChemical engineering.
650 0 _aPublic health.
650 0 _aBiochemistry.
650 0 _aMicrobiology.
650 0 _aBiomedical engineering.
650 1 4 _aChemistry.
650 2 4 _aIndustrial Chemistry/Chemical Engineering.
650 2 4 _aBiomedical Engineering.
650 2 4 _aPublic Health.
650 2 4 _aPolymer Sciences.
650 2 4 _aMedical Biochemistry.
650 2 4 _aMicrobiology.
700 1 _aBhatia, Sujata K.
_eauthor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9781461447580
830 0 _aSpringerBriefs in Public Health,
_x2192-3698
856 4 0 _uhttp://dx.doi.org/10.1007/978-1-4614-4759-7
912 _aZDB-2-CMS
999 _c101516
_d101516